| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 4
| Issue : 4 | Page : 152-155 |
|
|
Dysregulated immune response in SARS-CoV-2 infections
Marilaeta Cindryani, Bianca Jeanne, I Made Gede Widnyana
Department of Anesthesiology and Intensive Care, Faculty of Medicine, Udayana University, Bali, Indonesia
Correspondence Address:
Dr. Marilaeta Cindryani
Department of Anesthesiology and Intensive Care, Faculty of Medicine, Udayana University, Bali
Indonesia
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/BJOA.BJOA_116_20
|
|
|
Coronaviruses have caused several global challenges for health-care providers all over the world. The notorious SARS-CoV-2 could attack the lower respiratory tract and trigger the immune systems to release massive number of immune cells and pro-inflammatory cytokines and cause immunopathology consequences called cytokine release syndrome. These pro-inflammatory cytokines and other immune cells caused lung injury and severe acute respiratory distress syndrome in COVID-19 (CARDS) and multiple organ failure. There are still many intertwined immune responses that not yet been discovered in SARS-CoV-2 infections. Targeted and specific cell therapy would be reasonable and considered safer to be employed in patients who present with comorbidities and at risk of complications.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
